SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-14-003839
Filing Date
2014-08-08
Accepted
2014-08-08 15:29:33
Documents
17
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080814.htm 10-Q 933107
2 EXHIBIT 10.5 exh_105.htm EX-10.5 1731
3 EXHIBIT 10.6 exh_106.htm EX-10.6 1383
4 EXHIBIT 31.1 exh_311.htm EX-31.1 17213
5 EXHIBIT 31.2 exh_312.htm EX-31.2 17320
6 EXHIBIT 32.1 exh_321.htm EX-32.1 6895
7 EXHIBIT 32.2 exh_322.htm EX-32.2 6798
14 exh105_1.jpg GRAPHIC 414797
15 exh105_2.jpg GRAPHIC 248897
16 exh106_1.jpg GRAPHIC 407861
17 exh106_2.jpg GRAPHIC 204967
  Complete submission text file 0001171843-14-003839.txt   7385818

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT bcrx-20140630.xml EX-101.INS 941030
9 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20140630.xsd EX-101.SCH 44405
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20140630_cal.xml EX-101.CAL 27413
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20140630_def.xml EX-101.DEF 176606
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20140630_lab.xml EX-101.LAB 337680
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20140630_pre.xml EX-101.PRE 178440
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 141027279
SIC: 2836 Biological Products, (No Diagnostic Substances)